Psychological Effects of Different Voting Rules - Evidence from Romania
, 2012 Andra-Maria Roescu
openalex +1 more source
Skills, attitude and knowledge for early-career hematologists: a pragmatic, scientific framework. [PDF]
Clin Hematol IntMohty M, Ye Y, Banerjee R.
europepmc +1 more source
Rules of Procedure and Evidence [PDF]
African Journal of Legal Studies, 2008 openaire +1 more source
Next‐generation proteomics improves lung cancer risk prediction
Molecular Oncology, EarlyView.This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Improving causal models for election forecasting: Further evidence on the Golden Rule of Forecasting
, 2014 Andreas Graefe +2 more
openalex +2 more sources
Fiscal rules, powerful levers for controlling the health budget? Evidence from 32 OECD countries [PDF]
, 2018 H. Christiaan Schakel +2 more
openalex +1 more source
Applying the One Health approach to study the policy and institutional determinants to control and prevent zoonoses in a low-resource setting. [PDF]
Health Res Policy SystDumet L +7 more
europepmc +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
Molecular Oncology, EarlyView.This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
Molecular Oncology, EarlyView.WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source